Public company, workplace, funding, and market signals
CellChorus is a Houston/South San Francisco life-sciences company that uses the TIMING™ platform and visual AI to perform dynamic single-cell analysis for biopharma and cell-therapy workflows. Public sources place formation in 2017, although Y Combinator lists 2020, so the founding date is somewhat inconsistent across sources.
Primary product
TIMING™ (Time-lapse Imaging Microscopy in Nanowell Grids) platform
Founded
2017
Headquarters
Houston, Texas, United States
Team size
1-10
Industry
Biotechnology Research
Sub-industry
Single-cell analysis / life science tools
Offices
0 jobs at CellChorus
Check back later for new openings
Business model
Stage
Seed-stage, grant-backed
Total raised
$5.3M
Latest round
Phase I SBIR grant (NCI) · May 2026
Leadership
Chief Executive Officer
Chief Scientific Officer
Co-founder & Board Chair
Independent Director
Co-founder
Co-Founder and Board Director
Mission-driven, multidisciplinary team working at the intersection of artificial intelligence, advanced microscopy, and molecular profiling to improve human health.
Benefits
Pricing
Commercial service offering / custom TIMING assay service; no public list pricing found.
Differentiators
Technology
Customers
Competitors
Estimated revenue
Under $1M
Estimated monthly visits
1.3K
Traffic estimate as of May 2026